## Core Concept
The question pertains to the teratogenicity of drugs, which refers to the ability of a substance to cause malformations or defects in an embryo. Teratogenic effects can occur due to various factors including the timing, dose, and duration of exposure to the drug during pregnancy.

## Why the Correct Answer is Right
The correct answer, although not directly provided, implies that one of the statements regarding teratogenicity is not true. Typically, teratogenic drugs can cause a range of effects from minor anomalies to severe malformations. The critical period of organogenesis (first trimester) is a crucial time when exposure to teratogenic substances can lead to significant congenital anomalies.

## Why Each Wrong Option is Incorrect
- **Option A:** Without specific details on option A, we can infer that if it's listed as incorrect, it likely provides a statement that is not universally applicable or is misleading regarding teratogenicity.
- **Option B:** Similarly, if option B is incorrect, it might suggest a mechanism, example, or characteristic of teratogenic drugs that does not accurately reflect known teratogenic principles.
- **Option C:** This option would be incorrect based on similar reasoning, possibly presenting an exception or an inaccurate generalization about drug teratogenicity.

## Clinical Pearl / High-Yield Fact
A key point to remember is that the **teratogenic potential of a drug is often classified using the FDA's pregnancy categories**, which range from A (controlled studies show no risk) to X (studies in animals or humans have demonstrated fetal abnormalities). However, it's crucial to note that these categories are being phased out in favor of a more narrative description of the risk.

## Correct Answer: D.